278 related articles for article (PubMed ID: 33156095)
1. Hyponatremia in Cirrhosis: An Update.
Alukal JJ; John S; Thuluvath PJ
Am J Gastroenterol; 2020 Nov; 115(11):1775-1785. PubMed ID: 33156095
[TBL] [Abstract][Full Text] [Related]
2. Hyponatremia in cirrhosis: pathophysiology and management.
John S; Thuluvath PJ
World J Gastroenterol; 2015 Mar; 21(11):3197-205. PubMed ID: 25805925
[TBL] [Abstract][Full Text] [Related]
3. The kidney in cirrhosis with portal hypertension.
Olteanu D; Lupu D
J Med Life; 2010; 3(2):175-7. PubMed ID: 20968204
[TBL] [Abstract][Full Text] [Related]
4. [Hyponatremia in liver cirrhosis: pathogenesis and treatment].
Guevara M; Ginès P
Endocrinol Nutr; 2010 May; 57 Suppl 2():15-21. PubMed ID: 21130958
[TBL] [Abstract][Full Text] [Related]
5. Management of ascites and hepatorenal syndrome.
Piano S; Tonon M; Angeli P
Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
[TBL] [Abstract][Full Text] [Related]
6. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
Arroyo V; Jiménez W
J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis].
Ackermann D
Ther Umsch; 2009 Nov; 66(11):747-51. PubMed ID: 19885792
[TBL] [Abstract][Full Text] [Related]
8. Hypervolemic Hyponatremia (Liver).
Solà E; Ginès P
Front Horm Res; 2019; 52():104-112. PubMed ID: 32097916
[TBL] [Abstract][Full Text] [Related]
9. Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis.
Praharaj DL; Anand AC
J Clin Exp Hepatol; 2022; 12(2):575-594. PubMed ID: 35535075
[TBL] [Abstract][Full Text] [Related]
10. Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis.
Knotek M; Rogachev B; Schrier RW
Can J Gastroenterol; 2000 Nov; 14 Suppl D():112D-121D. PubMed ID: 11110623
[TBL] [Abstract][Full Text] [Related]
11. [Hyponatremia in Liver Cirrhosis].
Jang CM; Jung YK
Korean J Gastroenterol; 2018 Aug; 72(2):74-78. PubMed ID: 30145859
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs.
Barbano B; Sardo L; Gigante A; Gasperini ML; Liberatori M; Giraldi GD; Lacanna A; Amoroso A; Cianci R
Curr Vasc Pharmacol; 2014 Jan; 12(1):125-35. PubMed ID: 24678726
[TBL] [Abstract][Full Text] [Related]
13. Hyponatremia in Cirrhosis--Pathogenesis, Treatment, and Prognostic Significance.
Sinha VK; Ko B
Adv Chronic Kidney Dis; 2015 Sep; 22(5):361-7. PubMed ID: 26311597
[TBL] [Abstract][Full Text] [Related]
14. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
Schrier RW
Am J Med; 2006 Jul; 119(7 Suppl 1):S47-53. PubMed ID: 16843085
[TBL] [Abstract][Full Text] [Related]
15. [Current options of treatment of hyponatremia].
Tesař V
Vnitr Lek; 2016; 62 Suppl 6():97-101. PubMed ID: 28124939
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology and treatment of ascites and the hepatorenal syndrome.
Gentilini P; Laffi G
Baillieres Clin Gastroenterol; 1992 Sep; 6(3):581-607. PubMed ID: 1421601
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites.
Cárdenas A; Arroyo V
Best Pract Res Clin Endocrinol Metab; 2003 Dec; 17(4):607-22. PubMed ID: 14687592
[TBL] [Abstract][Full Text] [Related]
18. Physiopathology of ascites in portal hypertension.
Michielsen PP
Acta Gastroenterol Belg; 1996; 59(3):191-7. PubMed ID: 9015930
[TBL] [Abstract][Full Text] [Related]
19. Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II.
Møller S; Aagaard NK; Schmidt L; Grønbaek H; Hansen JB; Bendtsen F
Dan Med J; 2012 Jan; 59(1):C4372. PubMed ID: 22239848
[TBL] [Abstract][Full Text] [Related]
20. Fluid retention in cirrhosis: pathophysiology and management.
Kashani A; Landaverde C; Medici V; Rossaro L
QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
